Clinical Trial Update: To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atorvastatin plus a cholinesterase inhibitor in Alzheimer's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED